BioSpace News Archive

Business

Aileron Therapeutics Reports Third Quarter 2017 Financial Results

Cash, cash equivalents and investments as of September 30, 2017 were $56.9 million, compared to $20.7 million as of December 31, 2016.

November 10, 2017
·
11 min read
Business

BioCardia Reports Third Quarter 2017 Financial Results and Business Highlights

BioCardia reported a net loss of $3.0 million for the third quarter of 2017, which compares to a net loss of $3.3 million for the third quarter of 2016.

November 10, 2017
·
7 min read
Business

Tauriga Sciences Progresses Towards Commercial Launch of Its Licensed Proprietary Cupuacu Butter Lip Balm Product

The Companies expect that the marketable inventory, which incorporates the final formulation and packaging modification(s), could be delivered by Ariel Laboratories (the “Manufacturer”) as early as December 01, 2017.

November 10, 2017
·
5 min read
Sartorius Stedim Biotech Wins Frost & Sullivan Award for Customer Service Leadership in Bioanalytical Contract Testing

Presented at the Frost & Sullivan ceremony in London, UK, this award recognizes the unique product and service combination and enhanced customer satisfaction provided by Sartorius Stedim BioOutsource, SSB’s subsidiary based in Glasgow.

November 10, 2017
·
3 min read
Business

Caladrius Biosciences Reports 2017 Third Quarter Results

Conference call begins today at 4:30 p.m. Eastern Time.

November 10, 2017
·
10 min read
Business

Omeros Reports Third Quarter 2017 Financial Results

Omeros today announced recent highlights and developments as well as financial results for the third quarter ended September 30, 2017, which include:

November 10, 2017
·
12 min read
Business

Immunomedics Announces First Quarter Fiscal 2018 Results and Provides Corporate Update

Total revenue was $0.7 million for both quarters ended September 30, 2017 and September 30, 2016.

November 10, 2017
·
12 min read
Business

ICU Medical Announces Third Quarter 2017 Results

Third quarter 2017 revenue was $343.2 million, compared to $97.1 million in the same period last year.

November 10, 2017
·
21 min read
Business

Mersana Announces Third Quarter 2017 Financial Results and Provides Business Updates

Cash, cash equivalents and marketable securities as of September 30, 2017 were $133.4 million, compared with $100.3 million as of December 31, 2016.

November 10, 2017
·
9 min read
Business

Braskem Signs Partnership With Haldor Topsoe to Develop Biobased MEG

The agreement calls for the construction of a demonstration plant in Denmark, with operation slated to begin in 2019.

November 10, 2017
·
3 min read